RAD — Radiopharm Theranostics Share News
0.000.00%
- AU$70.88m
- AU$34.53m
- AU$3.63m
Brief: Radiopharm Theranostics Says Australia's Nuclear Science And Technology Organisation Deal
Brief: Radiopharm Theranostics Signs Agreement With Northstar Medical Radioisotopes For The Supply Of Non-Carrier Added Actinium-225
Brief: Radiopharm Theranostics Says Entered Into Clinical Supply Agreement
Brief: Radiopharm Theranostics Announces Entitlement Offer To Raise Up To A$10 Mln
Brief: Radiopharm Theranostics Seeks Trading Halt
Brief: Radiopharm Theranostics Says U.S. FDA Grants Rare Pediatric Disease Designation For Dunp19
Australia's Radiopharm Theranostics soars on FDA nod for osteosarcoma treatment
Brief: Radiopharm Theranostics Says MD Anderson And Co Launch JV
Australia's Radiopharm Theranostics climbs on orphan drug status for cancer treatment
Brief: Radiopharm Theranostics Says Loss For Year Of A$30.3 Million
Brief: Radiopharm Theranostics Enters Into Strategic Collaboration With Lantheus
Radiopharm And Isotopia Announce Supply Agreement For Lutetium-177 N.C.A
Australia Stock Exchange release from RADIOPHARM THERA : Investor Presentation
Brief: Radiopharm Theranostics Agreed Commercial Terms For Services In Signed Letter Of Intent With Genesiscare
Australia Stock Exchange release from RADIOPHARM THERA : PRE_NR Ends: 10:54:06
Australia Stock Exchange release from RADIOPHARM THERA : LOI with GenesisCare to start first trial in Australia
Australia Stock Exchange release from RADIOPHARM THERA : Change of Director's Interest Notice - IT
Australia Stock Exchange release from RADIOPHARM THERA : PRE_NR Ends: 10:33:21
Australia Stock Exchange release from RADIOPHARM THERA : Half Yearly Report and Accounts